A randomized phase III study comparing dacarbazine, BCNU, cisplatin and tamoxifen with dacarbazine and interferon in advanced melanoma
Open Access
- 1 March 2000
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 82 (6), 1158-1162
- https://doi.org/10.1054/bjoc.1999.1056
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Phase III Multicenter Randomized Trial of the Dartmouth Regimen Versus Dacarbazine in Patients With Metastatic MelanomaJournal of Clinical Oncology, 1999
- Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma. National Cancer Institute of Canada Clinical Trials Group.Journal of Clinical Oncology, 1996
- Dacarbazine (DTIC)-based chemotherapy or chemoimmunotherapy of patients with disseminated malignant melanomaBritish Journal of Cancer, 1994
- Multicenter randomized trial of dacarbazine alone or in combination with two different doses and schedules of interferon alfa-2a in the treatment of advanced melanoma.Journal of Clinical Oncology, 1994
- Sequential chemoimmunotherapy in the treatment of metastatic melanoma.1992
- Effective combination chemo/hormonal therapy for malignant melanoma: Experience with three consecutive trialsInternational Journal of Cancer, 1992
- Improved results with the addition of interferon alfa-2b to dacarbazine in the treatment of patients with metastatic malignant melanoma.Journal of Clinical Oncology, 1991
- Chemotherapy for malignant melanoma: combinations and high doses produce more responses without survival benefitBritish Journal of Cancer, 1990
- Combination chemotherapy with cisplatin, carmustine, dacarbazine, and tamoxifen in metastatic melanoma.1984
- Randomized phase III trial of vinblastine, bleomycin, and cis-dichlorodiammine-platinum versus dacarbazine in malignant melanoma.Journal of Clinical Oncology, 1984